Sameer M. Zuberi

Glasgow, SCT, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 136 publications

Hussam Abu Safiya: The medical community cannot remain passive as a senior paediatrician is left to die in an Israeli prison.

Hussam Abu Safiya: The medical community cannot remain passive as a senior paediatrician is left to die in an Israeli prison.

Journal: BMJ (Clinical research ed.)

Published: July 28, 2026

Changes in effectiveness and safety in patients with Lennox-Gastaut syndrome transitioning from the fenfluramine randomized controlled trial to open-label extension study.

Changes in effectiveness and safety in patients with Lennox-Gastaut syndrome transitioning from the fenfluramine randomized controlled trial to open-label extension study.

Journal: Epilepsia open

Published: April 01, 2026

Gene Portals: A Framework for Integrating Clinical, Functional, and Structural Evidence into Rare Disease Variant Classification.

Gene Portals: A Framework for Integrating Clinical, Functional, and Structural Evidence into Rare Disease Variant Classification.

Journal: medRxiv : the preprint server for health sciences

Published: March 13, 2026

Gene Portals: A Framework for Integrating Clinical, Functional, and Structural Evidence into Rare Disease Variant Classification.

Gene Portals: A Framework for Integrating Clinical, Functional, and Structural Evidence into Rare Disease Variant Classification.

Journal: medRxiv : the preprint server for health sciences

Published: March 13, 2026

Championing brain health of children with neurological and neurodevelopmental disorders who are experiencing armed conflict and displacement.

Championing brain health of children with neurological and neurodevelopmental disorders who are experiencing armed conflict and displacement.

Journal: Developmental medicine and child neurology

Published: January 16, 2026

Characterizing early behavioral and social-emotional problems in young children with SCN1A+ Dravet syndrome: Findings from the ENVISION prospective natural history study.

Characterizing early behavioral and social-emotional problems in young children with SCN1A+ Dravet syndrome: Findings from the ENVISION prospective natural history study.

Journal: Epilepsia

Published: October 20, 2025

Elicited Repetitive Daily Blindness Associated With Gain-of-Function SCN1A Variants and Responsiveness to Sodium Channel Blockers.

Elicited Repetitive Daily Blindness Associated With Gain-of-Function SCN1A Variants and Responsiveness to Sodium Channel Blockers.

Journal: Neurology. Genetics

Published: October 16, 2025

Respiratory monitoring and apnoea detection in paediatric and neonatal patients using a wearable accelerometer-based chest sensor: protocol for an observational diagnostic feasibility study.

Respiratory monitoring and apnoea detection in paediatric and neonatal patients using a wearable accelerometer-based chest sensor: protocol for an observational diagnostic feasibility study.

Journal: BMJ open

Published: August 31, 2025

Cognitive stagnation and executive function deficits in young children with SCN1A+ Dravet syndrome: Detailed characterization of onset, progression, and impact in the ENVISION natural history study.

Cognitive stagnation and executive function deficits in young children with SCN1A+ Dravet syndrome: Detailed characterization of onset, progression, and impact in the ENVISION natural history study.

Journal: Epilepsia

Published: July 23, 2025

Final analysis from an open-label extension study of fenfluramine for the treatment of seizures in Lennox-Gastaut syndrome: long-term impact on patients and caregivers.

Final analysis from an open-label extension study of fenfluramine for the treatment of seizures in Lennox-Gastaut syndrome: long-term impact on patients and caregivers.

Journal: Epilepsy & behavior : E&B

Published: July 18, 2025

Clinically Meaningful Reduction in Drop Seizures in Patients with Lennox-Gastaut Syndrome Treated with Cannabidiol: Post Hoc Analysis of Phase 3 Clinical Trials.

Clinically Meaningful Reduction in Drop Seizures in Patients with Lennox-Gastaut Syndrome Treated with Cannabidiol: Post Hoc Analysis of Phase 3 Clinical Trials.

Journal: CNS drugs

Published: June 08, 2025

Evaluation, Diagnosis, and Treatment of Sydenham Chorea: Consensus Guidelines.

Evaluation, Diagnosis, and Treatment of Sydenham Chorea: Consensus Guidelines.

Journal: Pediatrics

Published: May 13, 2025

Showing 1-12 of 136

Last Updated: 09/26/2026